SCHEMBL4530128

SCHEMBL4530128

Cc1nc(N)nc(N)c1-c1cccc(Br)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.55
DHFR P00374 4/20 0.49
HEXA P06865 2/20 0.49
HEXB P07686 2/20 0.49
KDM4E B2RXH2 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
RAB9A P51151 2/20 0.44
HK1 P19367 1/20 0.44
HKDC1 Q2TB90 1/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HRH2 P25021 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1882625 0.83 MAP4K4 (0.57) DHFRHEXAHEXBSMN1; SMN2RAB9A
SCHEMBL12368259 0.83 HEXA (0.68) DHFRHEXAHEXBALDH1A1RAB9A
Hydrochloric Acid SCHEMBL4532657 0.79 HEXA (0.48) DHFRHEXAHEXBRAB9A
SCHEMBL3500167 0.79 DHFR (0.61) DHFRHEXAHEXBKDM4ESMN1; SMN2
SCHEMBL4532674 0.77 NPC1 (0.43) DHFRHEXAHEXBRAB9ANPC1
Hydrochloric Acid SCHEMBL4518745 0.76 NPC1 (0.42) DHFRHEXAHEXBRAB9ANPC1
SCHEMBL7165985 0.76 HRH4 (0.50) IKBKBKMT2AHRH3
SCHEMBL6049535 0.75 IKBKB (0.56) IKBKBDHFRHEXAHEXBKDM4E
SCHEMBL4539404 0.75 HEXA (0.44) DHFRHEXAHEXB
SCHEMBL17495238 0.73 IKBKB (0.56) IKBKBKDM4ESMN1; SMN2RXFP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090018150-A1 5-Ht2b Receptor Antagonists ASTERAND UK LIMITED (GB) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018150-A1 5-Ht2b Receptor Antagonists HTR2B, HTR1B, HTR3B IKBKB 777/4885DHFR 1058/4885HEXA 748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.